Value
7.6/10data confidence 67%| Component | Sub-score |
|---|---|
| P/E | 8.3 |
| P/S | 10.0 |
| Fwd P/E | 9.0 |
| Analyst target | 4.0 |
- ▸Forward P/E: 12.1x
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
| Pillar | Expectation | Trend |
|---|---|---|
At a forward P/E of approximately 12.5x, the stock screens as attractively valued on an absolute basis, offering a potential margin of safety if revenue trends stabilize. Value | The forward multiple holds at or below 15x over the next 12 months as reported earnings remain steady, demonstrating that the cheap valuation reflects a genuine discount rather than deteriorating fundamentals. | →Stable |
| CounterCheap multiples can persist or compress further when revenue is contracting at 28%; without a growth catalyst, a low forward earnings multiple reflects risk rather than opportunity. | ||
Three of the four most recent quarters produced earnings beats; the most recent quarter came in line with estimates after three straight beats, suggesting the delivery cadence remains mostly intact even as the business contracts. Earnings | EPS surprises return to positive territory in the next two quarterly reports, confirming the in-line result was a one-quarter exception rather than the start of a deteriorating trend. | →Stable |
| CounterThe most recent in-line result may signal that guidance has absorbed the full impact of the revenue decline, leaving no cushion to beat from; future quarters could miss as volume pressure intensifies. | ||
Revenue declined approximately 28%, a deterioration that undermines any fundamental re-rating and signals that the core business faces material demand or structural headwinds that have yet to show signs of reversing. Growth | Revenue growth turns negative by a larger margin over the next two quarters, confirming the structural nature of the decline and validating the cautious stance. | →Stable |
| CounterA sharp revenue contraction can precede a trough recovery; if the underlying demand environment bottoms, the low valuation could re-rate quickly and the decline could prove cyclical rather than permanent. | ||
The 200-day moving average is declining at approximately 5.5% over the past 30 days, confirming a downtrend, and the stock is already trading above the near-term resistance target, leaving negative implied upside to that level. Momentum | The 200-day moving average slope continues its decline and price fails to sustain meaningfully above the resistance target, confirming the bearish technical setup. | →Stable |
| CounterVolume is accumulating (rising on-balance volume) and short-term momentum indicators are improving, suggesting early recovery interest that could turn the trend before the moving average confirms a reversal. | ||
CounterCheap multiples can persist or compress further when revenue is contracting at 28%; without a growth catalyst, a low forward earnings multiple reflects risk rather than opportunity.
CounterThe most recent in-line result may signal that guidance has absorbed the full impact of the revenue decline, leaving no cushion to beat from; future quarters could miss as volume pressure intensifies.
CounterA sharp revenue contraction can precede a trough recovery; if the underlying demand environment bottoms, the low valuation could re-rate quickly and the decline could prove cyclical rather than permanent.
CounterVolume is accumulating (rising on-balance volume) and short-term momentum indicators are improving, suggesting early recovery interest that could turn the trend before the moving average confirms a reversal.
The shares screen as attractively valued at roughly 12.5x forward earnings and have delivered beats in three of the last four quarters, but a 28% revenue contraction and a confirmed 200-day moving average downtrend mean the underlying business has not yet demonstrated the growth needed to support a re-rating; with the price already above the near-term resistance target, the risk/reward is unfavorable.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Component | Sub-score |
|---|---|
| P/E | 8.3 |
| P/S | 10.0 |
| Fwd P/E | 9.0 |
| Analyst target | 4.0 |
| Component | Sub-score |
|---|---|
| ROE | 1.4 |
| ROA | 0.7 |
| Gross margin | 10.0 |
| Op margin | 0.0 |
| Net margin | 9.0 |
| Current ratio | 5.0 |
| Moat | 6.1 |
| Piotroski F | 6.7 |
| Component | Sub-score |
|---|---|
| Rev growth | 0.0 |
| EPS growth | 0.0 |
| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 8.3 |
| OBV | 10.0 |
| MA position | 6.0 |
| Volume | 0.7 |
| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 5.9 |
| erm sentiment | 4.4 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.0 |
| Component | Sub-score |
|---|---|
| value rank | 7.8 |
| quality rank | 5.4 |
| growth rank | 0.0 |
| Component | Sub-score |
|---|---|
| bollinger | 2.9 |
| support resistance | 2.3 |
| 52w position | 3.5 |
| gap | 6.0 |
| Component | Sub-score |
|---|---|
| short interest | 8.1 |
| days to cover | 7.6 |
| volatility | 2.7 |
| put call | 0.0 |
| implied vol | 2.7 |
| beta | 10.0 |
| debt equity | 9.1 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 4.5 |
| dividend safety | 5.2 |
Multiple concerning factors. Consider reducing position.
L4:PATH_F_SELLSetupRecovery — Death cross but MACD improving, RSI 60
EdgeCatalyst-Driven — Earnings in 27d with 3/4 beat streak
SuitabilityAggressive — MCap $2.1B<$5B
The F-path SELL output reflects an overall score of 4.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 7.6) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.6=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.60 — supplementary context, not the trigger for this path.
The strongest dimensions are Value at 7.6, Momentum at 5.9, and Catalyst at 5.9; the weakest are Growth at 0.0, Technical at 3.7, and Quality at 4.9. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.60 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
Trip ifForward P/E compresses below 8x as earnings estimates are cut, indicating the cheap-valuation thesis has been overtaken by deteriorating fundamentals.
Trip ifRevenue growth turns positive and exceeds 5% year-over-year for 2 consecutive quarters, indicating the contraction is reversing.
Trip if200-day moving average slope turns positive and stock price rises more than 10% above the current resistance target of approximately $18.47.